Berchuck A - Search Results

1

Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer.

Hurteau JA, Woolas RP, Jacobs IJ, Oram DC, Kurman CC, Rubin LA, Nelson DL, Berchuck A, Bast RC Jr, Mills GB. Hurteau JA, et al. Among authors: berchuck a. Cancer. 1995 Nov 1;76(9):1615-20. doi: 10.1002/1097-0142(19951101)76:9<1615::aid-cncr2820760918>3.0.co;2-g. Cancer. 1995. PMID: 8635066 Clinical Trial.

2

The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cells.

Boente MP, Berchuck A, Rodriguez GC, Davidoff A, Whitaker R, Xu FJ, Marks J, Clarke-Pearson DL, Bast RC Jr. Boente MP, et al. Among authors: berchuck a. Am J Obstet Gynecol. 1992 Dec;167(6):1877-82. doi: 10.1016/0002-9378(92)91790-h. Am J Obstet Gynecol. 1992. PMID: 1361720

3

Ploidy analysis of epithelial ovarian cancers using image cytometry.

Berchuck A, Boente MP, Kerns BJ, Kinney RB, Soper JT, Clarke-Pearson DL, Bast RC Jr, Bacus SS. Berchuck A, et al. Gynecol Oncol. 1992 Jan;44(1):61-5. doi: 10.1016/0090-8258(92)90013-9. Gynecol Oncol. 1992. PMID: 1370427

4

Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancer.

Olt G, Berchuck A, Soisson AP, Boyer CM, Bast RC Jr. Olt G, et al. Among authors: berchuck a. Cancer. 1992 Oct 15;70(8):2137-42. doi: 10.1002/1097-0142(19921015)70:8<2137::aid-cncr2820700821>3.0.co;2-w. Cancer. 1992. PMID: 1394043

5

Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.

Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BA, Humphrey P, Berchuck A, Ponder BA, Bast RC Jr. Jacobs IJ, et al. Among authors: berchuck a. J Natl Cancer Inst. 1992 Dec 2;84(23):1793-8. doi: 10.1093/jnci/84.23.1793. J Natl Cancer Inst. 1992. PMID: 1433368

6

Biology and therapy with biologic agents in gynecologic cancer.

Wiener JR, Berchuck A, Bast RC Jr. Wiener JR, et al. Among authors: berchuck a. Curr Opin Oncol. 1992 Oct;4(5):946-54. doi: 10.1097/00001622-199210000-00020. Curr Opin Oncol. 1992. PMID: 1457511 Review.

7

Oncogenes in ovarian cancer.

Berchuck A, Kohler MF, Bast RC Jr. Berchuck A, et al. Hematol Oncol Clin North Am. 1992 Aug;6(4):813-27. Hematol Oncol Clin North Am. 1992. PMID: 1500387 Review.

8

Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta.

Berchuck A, Rodriguez G, Olt G, Whitaker R, Boente MP, Arrick BA, Clarke-Pearson DL, Bast RC Jr. Berchuck A, et al. Am J Obstet Gynecol. 1992 Feb;166(2):676-84. doi: 10.1016/0002-9378(92)91697-9. Am J Obstet Gynecol. 1992. PMID: 1536252

9

Overexpression and mutation of p53 in endometrial carcinoma.

Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, Soper JT, Clarke-Pearson DL, Bast RC Jr, Marks JR. Kohler MF, et al. Among authors: berchuck a. Cancer Res. 1992 Mar 15;52(6):1622-7. Cancer Res. 1992. PMID: 1540970

10

The use of tumor markers in the management of patients with gynecologic carcinomas.

Berchuck A, Boente MP, Bast RC Jr. Berchuck A, et al. Clin Obstet Gynecol. 1992 Mar;35(1):45-54. doi: 10.1097/00003081-199203000-00009. Clin Obstet Gynecol. 1992. PMID: 1544249 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

640 results

Search Page

Filters